Last reviewed · How we verify

NCT04662762

A Nursing Intervention Program to Improve Therapeutic Adherence in Elderly People With Acute Myocardial Infarction

Completed NA Last updated 14 December 2020
What this trial tests

NA trial testing Nursing intervention programme in Medication Adherence in 160 participants. Completed in 28 May 2020.

Timeline
1 April 2016
Primary endpoint
28 February 2020
28 May 2020

Quick facts

Lead sponsorHospital Universitari de Bellvitge
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment160
Start date1 April 2016
Primary completion28 February 2020
Estimated completion28 May 2020

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Universitari de Bellvitge

Who can join

75 and older, any sex, with Medication Adherence or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study was to assess the impact of a nursing intervention on therapeutic adherence in elderly patients after acute myocardial infarction compared to a control group

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Can an individualized adherence education program delivered by nurses improve therapeutic adherence in elderly people with acute myocardial infarction?: A randomized controlled study.
    Calvo E, Izquierdo S, Castillo R, César E, et al · · 2021 · cited 14× · PMID 34102371 · DOI 10.1016/j.ijnurstu.2021.103975

Verify or expand the search:

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

Other Hospital Universitari de Bellvitge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04662762.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing